PRME — Prime Medicine, Inc. | XLV Holdings | StockAdder

(PRME)

Prime Medicine, Inc.

Live chart and latest PRME stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

PRME News

Prime Medicine (NASDAQ:PRME) Trading Down 6.4% - Here's What Happened

Apr 10, 2026 Yahoo Finance

Jacob Funds Bets on Prime Medicine (PRME), a Next-Generation Gene Therapy Company

Feb 18, 2026 MSN

Prime Medicine (PRME) focuses on liver franchise with $191.4M cash runway

Mar 26, 2026 Gotrade

Prime Medicine, Inc. Common Stock (PRME) Stock Price Today & Analysis

Jan 13, 2026 Genetic Engineering and Biotechnology News

StockWatch: Data, Big Name Investors Drive Prime Medicine Stock Surge

Sep 22, 2025 Stock Titan

Prime Medicine posts $201M loss advancing gene-editing therapies

Mar 3, 2026 simplywall.st

Institutional investors in Prime Medicine, Inc. (NASDAQ:PRME) see US$110m decrease in market cap last week, although long-term gains have benefitted them.

Jan 31, 2026 Investing.com

Goldman Sachs reiterates Early-Stage Biotech rating on Prime Medicine stock

Nov 13, 2025 MarketBeat

Prime Medicine (NASDAQ:PRME) Stock Price Down 7.3% - What's Next?

Mar 27, 2026 Yahoo Finance

Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates

Mar 3, 2026 MarketBeat

Prime Medicine, Inc. (NASDAQ:PRME) Receives Consensus Rating of "Moderate Buy" from Brokerages

Mar 31, 2026 Yahoo Finance

LifeSci Capital Initiates Prime Medicine (PRME), Highlights One-and-Done Potential in Liver and Lung Diseases

Dec 31, 2025 MarketBeat

Prime Medicine (NASDAQ:PRME) Trading Up 5.6% - Time to Buy?

Mar 26, 2026 Yahoo Finance

Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates

Nov 7, 2025 Yahoo Finance

Prime Medicine, Inc. (PRME) Announces NEJM Publication Of PM359 Data